Valuation : Precision Therapeutics Inc

Market Cap 115M 99.08M 92.9M 84.8M 160M 10.99B 160M 1.1B 430M 5.55B 432M 422M 18.39B P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 106M 91.22M 85.53M 78.07M 147M 10.12B 148M 1.01B 396M 5.11B 397M 389M 16.93B EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript : Precision Therapeutics Inc

Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 115M
-0.78%-1.42%+2.96%+21.65% 50.47B
-6.00%-0.75%+447.48%+535.14% 44.56B
-0.24%+0.74%+37.18%+16.26% 43.08B
-1.55%-2.07%+19.83%+71.70% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+125.06% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.63%+27.62% 14.58B
-1.66%-1.25%+78.49%+42.97% 13.92B
Average -2.13%-1.06%+80.42%+111.08% 30.51B
Weighted average by Cap. -1.70%-1.06%+96.28%+129.03%

Financials

2024 2025
Net sales 1.62M 1.4M 1.31M 1.2M 2.26M 155M 2.26M 15.56M 6.07M 78.34M 6.1M 5.96M 260M 125K 108K 101K 92.4K 174K 11.97M 175K 1.2M 469K 6.04M 470K 460K 20.04M
Net income -12.66M -10.91M -10.23M -9.34M -17.6M -1.21B -17.65M -121M -47.36M -611M -47.55M -46.51M -2.03B -233M -201M -188M -172M -324M -22.28B -325M -2.23B -872M -11.25B -875M -856M -37.29B
Net Debt 1.4M 1.2M 1.13M 1.03M 1.94M 133M 1.95M 13.38M 5.22M 67.37M 5.24M 5.13M 223M -9.12M -7.86M -7.37M -6.73M -12.68M -872M -12.72M -87.46M -34.13M -440M -34.26M -33.51M -1.46B
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-